Association of Exposure to Di-2-Ethylhexylphthalate Replacements With Increased Blood Pressure in Children and Adolescents

Hypertension

Volumn 66, Issue 2, 2015, Pages 301-308

  Trasande, Leonardo ^a,b,c,d   Attina, Teresa M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

Blood pressure; Children; Cross sectional studies; Endocrine disrupting chemicals; High density lipoproteins; Hypertyension; Triglycerides

Indexed keywords

COSMETIC; COTININE; CREATININE; DI ISODECYL PHTHALATE; DI ISONONYL PHTHALATE; LIPID; LIPOPROTEIN; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; DIISODECYL PHTHALATE; DIISONONYL PHTHALATE; ENDOCRINE DISRUPTOR;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; ARTICLE; BEHAVIOR; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHILD; CHILD HEALTH; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIET; DISEASE ASSOCIATION; DYSLIPIDEMIA; ELEVATED BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH SURVEY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY; URINE LEVEL; BLOOD PRESSURE; COMPARATIVE STUDY; HYPERTENSION; INCIDENCE; MULTIVARIATE ANALYSIS; NUTRITION; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; UNITED STATES; URINE;

ADOLESCENT; BLOOD PRESSURE; CHILD; CROSS-SECTIONAL STUDIES; DIETHYLHEXYL PHTHALATE; ENDOCRINE DISRUPTORS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; PHTHALIC ACIDS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84937566882     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05603     Document Type: Article

References (54)

1. Sathyanarayana S., Phthalates and children's health. Curr Probl Pediatr Adolesc Health Care 2008;38:34-49. doi: 10.1016/j.cppeds.2007.11.001
2. Schettler T., Human exposure to phthalates via consumer products. Int J Androl 2006;29:134-139.; discussion 181. doi: 10.1111/j.1365-2605.2005.00567.x
3. Koch HM, Calafat AM., Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci 2009;364:2063-2078. doi: 10.1098/rstb.2008.0208
4. Fromme H, Gruber L, Schlummer M, Wolz G, Böhmer S, Angerer J, Mayer R, Liebl B, Bolte G., Intake of phthalates and di(2-ethylhexyl)adipate: Results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data. Environ Int 2007;33:1012-1020. doi: 10.1016/j.envint.2007.05.006
5. US Agency for Toxic Substances & Disease Registry Toxicological Profile for Di-2-Ethylhexylphthalate. Available at http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=684&tid=65. Accessed February 14, 2015
6. ECHA (European Chemicals Agency) 2013. Evaluation of New Scientific Evidence Concerning DINP and DIDP in Relation to Entry 52 of Annex XVII to Reach Regulation (EC) No 1907/2006 (Final Review Report). Available at http://echa.europa.eu/documents/10162/31b4067e-de40-4044-93e8-9c9ff1960715. Accessed February 23, 2015.
7. Silva MJ, Samandar E, Preau JL Jr, Reidy JA, Needham LL, Calafat AM., Quantification of 22 phthalate metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 2007;860:106-112. doi: 10.1016/j.jchromb.2007.10.023
8. Toxic Substance Control Act. 1976. Available at http://www.epw.senate.gov/tsca.pdf. Accessed March 30, 2015.
9. Kim SH, Park MJ., Phthalate exposure and childhood obesity. Ann Pediatr Endocrinol Metab 2014;19:69-75. doi: 10.6065/apem.2014.19.2.69
10. Newbold RR, Padilla-Banks E, Snyder RJ, Phillips TM, Jefferson WN., Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol 2007;23:290-296. doi: 10.1016/j.reprotox.2006.12.010
11. Jepsen KF, Abildtrup A, Larsen ST., Monophthalates promote IL-6 and IL-8 production in the human epithelial cell line A549. Toxicol In Vitro 2004;18:265-269. doi: 10.1016/j.tiv.2003.09.008
12. Gourlay T, Samartzis I, Stefanou D, Taylor K., Inflammatory response of rat and human neutrophils exposed to di-(2-ethyl-hexyl)-phthalate-plasticized polyvinyl chloride. Artif Organs 2003;27:256-260.
13. Ban JB, Fan XW, Huang Q, Li BF, Chen C, Zhang HC, Xu SQ., Mono-(2-ethylhexyl) phthalate induces injury in human umbilical vein endothelial cells. PLoS One 2014 9 e97607. doi: 10.1371/journal.pone.0097607
14. Ferguson KK, Loch-Caruso R, Meeker JD., Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999-2006. Environ Res 2011;111:718-726. doi: 10.1016/j.envres.2011.02.002
15. Hong YC, Park EY, Park MS, Ko JA, Oh SY, Kim H, Lee KH, Leem JH, Ha EH., Community level exposure to chemicals and oxidative stress in adult population. Toxicol Lett 2009;184:139-144. doi: 10.1016/j.toxlet.2008.11.001
16. Ji K, Lim Kho Y, Park Y, Choi K., Influence of a five-day vegetarian diet on urinary levels of antibiotics and phthalate metabolites: A pilot study with "Temple Stay" participants. Environ Res 2010;110:375-382. doi: 10.1016/j.envres.2010.02.008
17. Trasande L, Attina TM, Trachtman H., Bisphenol A exposure is associated with low-grade urinary albumin excretion in children of the United States. Kidney Int 2013;83:741-748. doi: 10.1038/ki.2012.422
18. Trasande L, Sathyanarayana S, Trachtman H., Dietary phthalates and low-grade albuminuria in US children and adolescents. Clin J Am Soc Nephrol 2014;9:100-109. doi: 10.2215/CJN.04570413
19. Ochodnicky P, Henning RH, van Dokkum RP, de Zeeuw D., Microalbuminuria and endothelial dysfunction: Emerging targets for primary prevention of end-organ damage. J Cardiovasc Pharmacol 2006 47 (suppl 2) S151 162; discussion S172-156
20. Bility MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, Peters JM., Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol Sci 2004;82:170-182. doi: 10.1093/toxsci/kfh253
21. Hamblin M, Chang L, Fan Y, Zhang J, Chen YE., PPARs and the cardiovascular system. Antioxid Redox Signal 2009;11:1415-1452. doi: 10.1089/ARS.2008.2280
22. Trasande L, Sathyanarayana S, Spanier AJ, Trachtman H, Attina TM, Urbina EM., Urinary phthalates are associated with higher blood pressure in childhood. J Pediatr 2013;163:747-53.e1. doi: 10.1016/j.jpeds.2013.03.072
23. Zota AR, Calafat AM, Woodruff TJ., Temporal trends in phthalate exposures: Findings from the National Health and Nutrition Examination Survey, 2001-2010. Environ Health Perspect 2014;122:235-241. doi: 10.1289/ehp.1306681
24. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL, Calafat AM., Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 2004;112:331-338.
25. Ostchega Y, Prineas RJ, Paulose-Ram R, Grim CM, Willard G, Collins D., National Health and Nutrition Examination Survey 1999-2000: Effect of observer training and protocol standardization on reducing blood pressure measurement error. J Clin Epidemiol 2003;56:768-774.
26. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT., Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med 2009;163:371-377. doi: 10.1001/archpediatrics.2009.3
27. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL., Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
28. US Department of Agriculture Dietary Guidelines for Americans. Available at http://health.gov/dietaryguidelines/2010.asp. Accessed March 23, 2015.
29. Weitzman M, Cook S, Auinger P, Florin TA, Daniels S, Nguyen M, Winickoff JP., Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation 2005;112:862-869. doi: 10.1161/CIRCULATIONAHA.104.520650
30. US Centers for Disease Control and Prevention Overview of NHANES Survey Design and Weights. Available at http://www.cdc.gov/nchs/tutorials/dietary/SurveyOrientation/SurveyDesign/intro.htm. Accessed February 24, 2015.
31. Jones MP., Indicator and stratification methods for missing explanatory variables in multiple linear regression. J Am Stat Assoc 1996;91:222-230.
32. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH., Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect 2007;115:876-882. doi: 10.1289/ehp.9882
33. Rubin D., Multiple Imputation for Nonresponse in Surveys 1987 New York John Wiley & Sons
34. Hurst CH, Waxman DJ., Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci 2003;74:297-308. doi: 10.1093/toxsci/kfg145
35. Rosado-Berrios CA, Vélez C, Zayas B., Mitochondrial permeability and toxicity of diethylhexyl and monoethylhexyl phthalates on TK6 human lymphoblasts cells. Toxicol In Vitro 2011;25:2010-2016. doi: 10.1016/j.tiv.2011.08.001
36. Hoppin JA, Brock JW, Davis BJ, Baird DD., Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ Health Perspect 2002;110:515-518.
37. Ostrow V, Wu S, Aguilar A, Bonner R Jr, Suarez E, De Luca F., Association between oxidative stress and masked hypertension in a multi-ethnic population of obese children and adolescents. J Pediatr 2011;158:628-633.e1. doi: 10.1016/j.jpeds.2010.09.081
38. Warolin J, Coenen KR, Kantor JL, Whitaker LE, Wang L, Acra SA, Roberts LJ II, Buchowski MS., The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth. Pediatr Obes 2014;9:43-52. doi: 10.1111/j.2047-6310.2012.00135.x
39. Zhang YH, Chen BH, Zheng LX, Wu XY., [Study on the level of phthalates in human biological samples]. Zhonghua Yu Fang Yi Xue Za Zhi 2003;37:429-434.
40. Zeng Q, Wei C, Wu Y, Li K, Ding S, Yuan J, Yang X, Chen M., Approach to distribution and accumulation of dibutyl phthalate in rats by immunoassay. Food Chem Toxicol 2013;56:18-27. doi: 10.1016/j.fct.2013.01.045
41. Mes J, Coffin DE, Campbell DS., Di-n-butyl-and di-2-ethylhexyl phthalate in human adipose tissue. Bull Environ Contam Toxicol 1974;12:721-725.
42. Fleiss JL, Shrout PE., The effects of measurement errors on some multivariate procedures. Am J Public Health 1977;67:1188-1191.
43. Kobrosly RW, Parlett LE, Stahlhut RW, Barrett ES, Swan SH., Socioeconomic factors and phthalate metabolite concentrations among United States women of reproductive age. Environ Res 2012;115:11-17. doi: 10.1016/j.envres.2012.03.008
44. Koo JW, Parham F, Kohn MC, Masten SA, Brock JW, Needham LL, Portier CJ., The association between biomarker-based exposure estimates for phthalates and demographic factors in a human reference population. Environ Health Perspect 2002;110:405-410.
45. Teitelbaum SL, Mervish N, Moshier EL, Vangeepuram N, Galvez MP, Calafat AM, Silva MJ, Brenner BL, Wolff MS., Associations between phthalate metabolite urinary concentrations and body size measures in New York City children. Environ Res 2012;112:186-193. doi: 10.1016/j.envres.2011.12.006
46. Reinehr T, Wunsch R, Pütter C, Scherag A., Relationship between carotid intima-media thickness and metabolic syndrome in adolescents. J Pediatr 2013;163:327-332. doi: 10.1016/j.jpeds.2013.01.032
47. Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM., Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich) 2011;13:332-342. doi: 10.1111/j.1751-7176.2011.00471.x
48. May AL, Kuklina EV, Yoon PW., Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics 2012;129:1035-1041. doi: 10.1542/peds.2011-1082
49. Rosner B, Cook NR, Daniels S, Falkner B., Childhood blood pressure trends and risk factors for high blood pressure: The NHANES experience 1988-2008. Hypertension 2013;62:247-254. doi: 10.1161/HYPERTENSIONAHA.111.00831
50. Mankidy R, Wiseman S, Ma H, Giesy JP., Biological impact of phthalates. Toxicol Lett 2013;217:50-58. doi: 10.1016/j.toxlet.2012.11.025
51. Posnack NG, Swift LM, Kay MW, Lee NH, Sarvazyan N., Phthalate exposure changes the metabolic profile of cardiac muscle cells. Environ Health Perspect 2012;120:1243-1251. doi: 10.1289/ehp.1205056
52. Ferguson KK, McElrath TF, Meeker JD., Environmental phthalate exposure and preterm birth. JAMA Pediatr 2014;168:61-67. doi: 10.1001/jamapediatrics.2013.3699
53. Sutherland MR, Bertagnolli M, Lukaszewski MA, Huyard F, Yzydorczyk C, Luu TM, Nuyt AM., Preterm birth and hypertension risk: The oxidative stress paradigm. Hypertension 2014;63:12-18. doi: 10.1161/HYPERTENSIONAHA.113.01276
54. Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ., Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab 2015 jc20144324